Neuroone Medical Technologies (NMTC) EBIT Growth (3y) (2013 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -3.76% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 8.39% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 1.70% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 25.88% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 7.13% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 34.83% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 75.54% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -2.70% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | -24.91% |
| 10 | Neuroone Medical Technologies | 31.39 Mn | 28.59 Mn | 1.29 Mn | 15.61% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 15.61% |
| Dec 31, 2025 | 1.46% |
| Sep 30, 2025 | 0.70% |
| Jun 30, 2025 | 11.93% |
| Mar 31, 2025 | 4.32% |
| Dec 31, 2024 | 37.67% |
| Sep 30, 2024 | -2.13% |
| Jun 30, 2024 | 2.72% |
| Mar 31, 2024 | -6.40% |
| Dec 31, 2023 | -16.52% |
| Sep 30, 2023 | -199.82% |
| Jun 30, 2023 | -30.12% |
| Mar 31, 2023 | -36.41% |
| Dec 31, 2022 | 0.55% |
| Sep 30, 2022 | -1.14% |
| Jun 30, 2022 | -14.02% |
| Mar 31, 2022 | -26.23% |
| Jun 30, 2021 | -37.31% |
| Mar 31, 2021 | -29.72% |
| Dec 31, 2020 | -40.44% |
| Sep 30, 2020 | 49.16% |
| Jun 30, 2020 | -21.49% |
| Mar 31, 2020 | -38.71% |
| Dec 31, 2019 | -114.94% |
| Sep 30, 2019 | -439.91% |
| Jun 30, 2019 | -409.23% |
| Mar 31, 2019 | -602.58% |
| Jun 30, 2018 | -297.48% |
| Mar 31, 2018 | -743.45% |
| Jun 30, 2017 | -281.39% |
| Mar 31, 2017 | -409.67% |
| Dec 31, 2016 | -313.53% |
| Sep 30, 2016 | -22.05% |
| Jun 30, 2016 | 1.57% |
| Mar 31, 2016 | -13.69% |
| Dec 31, 2015 | -86.22% |
| Sep 30, 2015 | 18.21% |
| Jun 30, 2015 | -101.37% |
| Mar 31, 2015 | 30.80% |
| Jun 30, 2014 | -138.42% |
| Mar 31, 2014 | 16.36% |
| Dec 31, 2013 | -67.77% |
| Sep 30, 2013 | 3.10% |